Search by Drug Name or NDC
NDC 42571-0348-05 Fenofibric acid 135 mg/1 Details
Fenofibric acid 135 mg/1
Fenofibric acid is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Micro Labs Limited. The primary component is FENOFIBRIC ACID.
MedlinePlus Drug Summary
Fenofibrate is used with a low-fat diet, exercise, and sometimes with other medications to reduce the amounts of fatty substances such as cholesterol and triglycerides in the blood and to increase the amount of HDL (high-density lipoprotein; a type of fatty substance that decreases the risk of heart disease) in the blood. Build-up of cholesterol and fats along the walls of the arteries (a process known as atherosclerosis) decreases the blood flow and, therefore, the oxygen supply to the heart, brain, and other parts of the body. This increases the risk of heart disease, angina (chest pain), strokes, and heart attacks. Although fenofibrate decreases the levels of fatty substances in the blood, it has not been shown to decrease the risk of heart attacks or strokes. Fenofibrate is in a class of medications called antilipemic agents. It works by speeding the natural processes that remove cholesterol from the body.
Related Packages: 42571-0348-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fenofibrate
Product Information
| NDC | 42571-0348 |
|---|---|
| Product ID | 42571-348_ee833c1c-286f-61c4-e053-2995a90a30f1 |
| Associated GPIs | 39200006006540 |
| GCN Sequence Number | 064677 |
| GCN Sequence Number Description | fenofibric acid (choline) CAPSULE DR 135 MG ORAL |
| HIC3 | M4E |
| HIC3 Description | LIPOTROPICS |
| GCN | 16105 |
| HICL Sequence Number | 036019 |
| HICL Sequence Number Description | FENOFIBRIC ACID (CHOLINE) |
| Brand/Generic | Generic |
| Proprietary Name | Fenofibric acid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fenofibric acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, DELAYED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 135 |
| Active Ingredient Units | mg/1 |
| Substance Name | FENOFIBRIC ACID |
| Labeler Name | Micro Labs Limited |
| Pharmaceutical Class | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213450 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42571-0348-05 (42571034805)
| NDC Package Code | 42571-348-05 |
|---|---|
| Billing NDC | 42571034805 |
| Package | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42571-348-05) |
| Marketing Start Date | 2020-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |